149 related articles for article (PubMed ID: 9892167)
1. AT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries.
Thorup C; Kornfeld M; Goligorsky MS; Moore LC
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S220-4. PubMed ID: 9892167
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries.
Thorup C; Kornfeld M; Winaver JM; Goligorsky MS; Moore LC
Pflugers Arch; 1998 Feb; 435(3):432-4. PubMed ID: 9426302
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide participates in the renal vasodilatory effect of candesartan in anesthetized rats.
Demeilliers B; Mimran A; Jover B
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S208-12. PubMed ID: 9892165
[TBL] [Abstract][Full Text] [Related]
4. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
5. Role of shear stress in nitric oxide-dependent modulation of renal angiotensin II vasoconstriction.
Endlich K; Muller C; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1999 Aug; 127(8):1929-35. PubMed ID: 10482926
[TBL] [Abstract][Full Text] [Related]
6. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
7. Evidence that nitric oxide regulates AT1-receptor agonist and antagonist efficacy in rat injured carotid artery.
Lemay J; Hou Y; deBlois D
J Cardiovasc Pharmacol; 2000 May; 35(5):693-9. PubMed ID: 10813369
[TBL] [Abstract][Full Text] [Related]
8. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide.
Guan Z; Willgoss DA; Matthias A; Manley SW; Crozier S; Gobe G; Endre ZH
Acta Physiol Scand; 2003 Oct; 179(2):189-201. PubMed ID: 14510783
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-induced enhancement of excitatory junction potentials evoked by periarteriolar nerve stimulation and vasoconstriction in rat mesenteric arteries are both mediated by the angiotensin AT1 receptor.
Ziogas J; Vessey K
Pharmacology; 2001; 63(2):103-11. PubMed ID: 11490203
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
11. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
Muller C; Endlich K; Helwig JJ
Br J Pharmacol; 1998 Jul; 124(5):946-52. PubMed ID: 9692780
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Banks T; Oyekan A
J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor.
Thai H; Wollmuth J; Goldman S; Gaballa M
J Pharmacol Exp Ther; 2003 Dec; 307(3):1171-8. PubMed ID: 14560036
[TBL] [Abstract][Full Text] [Related]
15. The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S95-7. PubMed ID: 9892147
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptors.
Ardaillou R
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S30-9. PubMed ID: 9892138
[TBL] [Abstract][Full Text] [Related]
18. AT1 calcium signaling in renal vascular smooth muscle cells.
Iversen BM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S84-9. PubMed ID: 9892145
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
Kalinowski L; Matys T; Chabielska E; Buczko W; Malinski T
Hypertension; 2002 Oct; 40(4):521-7. PubMed ID: 12364357
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S101-3. PubMed ID: 9892149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
